Canada markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.9700+0.0500 (+1.71%)
At close: 04:00PM EDT
2.9999 +0.03 (+1.01%)
After hours: 07:28PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 497.66M
Enterprise Value 144.08M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.82k
Price/Book (mrq)0.97
Enterprise Value/Revenue 1.52k
Enterprise Value/EBITDA -0.48

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-55.76%
S&P500 52-Week Change 321.33%
52 Week High 36.8900
52 Week Low 32.2300
50-Day Moving Average 34.2116
200-Day Moving Average 33.6898

Share Statistics

Avg Vol (3 month) 32.31M
Avg Vol (10 day) 32.18M
Shares Outstanding 5170.72M
Implied Shares Outstanding 6170.72M
Float 8116.93M
% Held by Insiders 122.21%
% Held by Institutions 172.76%
Shares Short (Apr 15, 2024) 431.36M
Short Ratio (Apr 15, 2024) 413.77
Short % of Float (Apr 15, 2024) 428.54%
Short % of Shares Outstanding (Apr 15, 2024) 418.40%
Shares Short (prior month Mar 15, 2024) 427.75M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)163,475.00%

Management Effectiveness

Return on Assets (ttm)-26.84%
Return on Equity (ttm)-55.51%

Income Statement

Revenue (ttm)95k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -300.29M
Net Income Avi to Common (ttm)-327.26M
Diluted EPS (ttm)-2.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)448.7M
Total Cash Per Share (mrq)2.65
Total Debt (mrq)95.12M
Total Debt/Equity (mrq)18.57%
Current Ratio (mrq)12.38
Book Value Per Share (mrq)3.04

Cash Flow Statement

Operating Cash Flow (ttm)-237.73M
Levered Free Cash Flow (ttm)-134.26M